Research & Insights
September 25, 2024
Lazard Global Biopharmaceutical Leaders Study 2024
Biopharmaceutical and biotech investors concluded the summer of 2024 facing ongoing uncertainty.
Lazard Healthcare Services Leaders Study 2024
Lazard Healthcare Services Leaders Study 2024
Lazard Global Biopharmaceutical Leaders Study 2023
The biopharma industry continues to be challenged by increased equity market volatility, following a period of unprecedented optimism and interest from generalists during the COVID-19 pandemic.
